Global Molecular Diagnostics Market Report: 2014 Edition – New Report by Koncept Analytics

Vaishali, India, July 24, 2014 --(PR.com)-- Despite having one of the world’s highest penetration rates of contraceptives, the US has been experiencing a rise in prevalence of sexually transmitted diseases (or that of CT/NG and HPV to be precise). Moreover, the country’s oncology patient pool has been projected to nudge towards the billion mark by the end of 2020. These two conditions, along with the fact that the US serves as the biggest market for the molecular diagnostics industry, provides a fertile ground for the future growth of the industry. The market prevails under the larger umbrella of the In Vitro Diagnostics, the ‘silent champion’ of the healthcare industry.

As per the report, “Global Molecular Diagnostics Market Report: 2014 Edition,” rising healthcare expenditure, increasing incidence of STDs, aging population, improving economic conditions, ballooning oncology patient pool and waning price responsiveness continue to be conducive towards encouraging the industry’s growth. Furthermore, growing awareness about point-of-care diagnostics and industry consolidation extend the growth potential for the same. However, ambiguity regarding reimbursement guidelines and stricter regulations pose as the major challenges for the industry.

Purchase by Section also Available:
Buy a Copy of This Report:
http://www.konceptanalytics.com/Researchreport/global-molecular-diagnostics-market-report-2014-edition-143.aspx

The report throws light on the major players that are shaping the industry: their market standing and business strategies against the backdrop of overall competitive landscape of the industry which have also been presented.

The report also encompasses major trends, growth drivers as well as issues being faced by the global industry. Recent as well as future developments affecting the industry have also been presented. By deploying SPSS Inc.’s data integration and analysis capabilities, future growth prediction in terms of value of the industry has also been analyzed in the report.

Note: Purchase by Section also Available:

List of Charts
IVD Market – Segments by Technology
Molecular Diagnostcs – Traditional Process
Main Purposes of Molecular Diagnostics
IVD Market Segment/Product Line
Global IVD Market (2006-2013E)
Global IVD Market Share by Segment (2013)
IVD Market Share by Geographical Region (2013E)
Global Molecular Diagnostics Market (2005-2013E)
Molecular Diagnostics Market Share by Segment (2013)
Molecular Diagnostics Market Share by Discipline (2013E)
Global HPV Market by Value (2010-2014E)
Global HPV Market by Volume (2010-2014E)
Global Pap Test Market (2013E)
Estimated Penetration of Liquid Based Cytology Tests (2012)
Global CT/NG Market by Value (2011-2015E)
Global CT/NG Market by Volume (2011-2015E)
Global Genetic Testing Market (2007-2013E)
Molecular Laboratories by Testing Menu
Global Average Selling Price (2010-2014E)
Incidence of Chlamydia and Gonorrhoea in the US (2000-2012)
Global Ageing Population (2007-2013)
Ageing Population in China (2008-2014)
Comparison of Aging Population (2012)
Global Healthcare Spending (2005-2015E)
Global GDP (2001-2013)
World GDP per Capita (2005-2013)
World Diabetic Population (2006-2013)
Oncology Market, the US (2014-2020E)
Global IVD Market Share by Company (2013E)
Global Molecular Diagnostics Market Share by Company (2013)
Global CT/NG Market Share by Company (2013)
Movements in Global CT/NG Market Share (2011-2014E)
Global HPV Market Share by Company (2013)
Movements in Global HPV Market Share (2010-2014E)
Roche’s Revenues by Business Segments (2013)
Diagnostics’ Revenues by Sub-Segments, Roche (2013)
Revenues and Net Income, Roche (2010-2013)
R&D Investments, Roche (2010-2013)
Novartis’ Revenue Share by Business Segments (2013)
Novartis’ Vaccines and Diagnostics’ Revenues by Geographies (2013)
Net Sales and Net Income, Novartis (2010-2013)
Revenue Share by Business Segments, Hologic (2013)
Revenue Share by Geographies, Hologic (2013)
Revenue and Net Income, Hologic (2010-2013)
Revenue Share by Customer Classes Served, Qiagen (2013)
Revenue Share by Geographies, Qiagen (2013)
Net Sales and Net Income, Qiagen (2010-2013)
Global Molecular Diagnostics Market Forecast (2007-2017F)

List of Tables
Major M&A in Diagnostics
Cancer Care Cost by Cancer Site (2010 and 2020E)
Top 20 IVD Companies by Revenue (2012)
Growth of Molecular Companies (2002-2012)
Dependent & Independent Variables (2007-2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

For more Information:
http://www.konceptanalytics.com/Researchreport/global-molecular-diagnostics-market-report-2014-edition-143.aspx

Koncept Analytics
Vikas Gupta
(Business Development Manager)
FFCS-36, Ansal Plaza
Vaishali, Ghaziabad
U.P - 201010
Tele: +91-120-4130959
Mobile: +91-9811715635
Mail ID - vikas@konceptanalytics.com